Lasiodin

CAS No. 28957-08-6

Lasiodin( Lasiokaurin )

Catalog No. M29178 CAS No. 28957-08-6

Lasiodin has anti-oxidative, and antineoplastic activities, it also shows antibacterial activity, esp. against Sarcina lutea.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 353 In Stock
5MG 313 In Stock
10MG 454 In Stock
25MG 729 In Stock
50MG 918 In Stock
100MG 1293 In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Lasiodin
  • Note
    Research use only, not for human use.
  • Brief Description
    Lasiodin has anti-oxidative, and antineoplastic activities, it also shows antibacterial activity, esp. against Sarcina lutea.
  • Description
    Lasiodin has anti-oxidative, and antineoplastic activities, it also shows antibacterial activity, esp. against Sarcina lutea.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    Lasiokaurin
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    P450
  • Recptor
    P450
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    28957-08-6
  • Formula Weight
    406.475
  • Molecular Formula
    C22H30O7
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [H][C@@]12CC[C@@H]3[C@@H](O)[C@]1(C(=O)C3=C)[C@@]1(O)OC[C@]22[C@H](CCC(C)(C)[C@@]2([H])[C@@H]1O)OC(C)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • N-Nornuciferine hydr...

    N-Nornuciferine is an aporphine alkaloid in lotus leaf, significantly inhibits CYP2D6 (IC50: 3.76 μM, Ki: 2.34 μM).N-Nornuciferine strongly inhibits CYP2D6 activity but shows weak or no inhibition of the other four P450 isoenzymes (CYP2C19, CYP3A4, CYP2E1, CYP2C9). N-Nornuciferine competitively inhibits the CYP2D6-catalyzed dextromethorphan O-demethylation (Ki: 2.34 μM).

  • N-Desmethyl-Apalutam...

    N-Desmethyl-Apalutamide is a less potent antagonist of the androgen receptor, is an active Apalutamide metabolite.

  • Dehydroabiethylamine

    Dehydroabiethylamine is an inducer of hepatic CYP2B activity.